Position in PFE
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$351,784
-$56,246 QoQ
Shares Held
14,609
+0.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#2,006
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SHEETS SMITH WEALTH MANAGEMENT holds $34,544,473 across 9 Drug Manufacturers - General names. PFE ranks #8 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
14,264 | $17,108,670 | |
| 2 | AMGN |
Amgen Inc
|
17,231 | $6,239,689 | |
| 3 | ABBV |
AbbVie Inc.
|
14,811 | $3,727,040 | |
| 4 | JNJ |
Johnson & Johnson
|
11,131 | $2,826,940 | |
| 5 | MRK |
Merck & Co., Inc.
|
21,343 | $2,742,575 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
7,247 | $915,585 | |
| 7 | NVS |
Novartis AG
|
2,450 | $383,964 | |
| 8 | PFE |
Pfizer Inc
This page
|
14,609 | $351,784 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $351,784 | 14,609 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $408,030 | 14,531 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $368,769 | 14,810 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $484,476 | 19,014 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $603,236 | 24,886 | Shares | Sole | 2025-07-15 | |
| 2025-03-31 | $1,318,592 | 52,036 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $1,416,834 | 53,405 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $1,560,936 | 53,937 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $1,590,187 | 56,833 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $1,843,959 | 66,449 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $1,215,398 | 42,216 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,696,380 | 51,142 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $1,915,246 | 52,215 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $2,121,232 | 51,991 | Shares | Sole | 2023-05-26 | |
| 2022-12-31 | $2,696,248 | 52,620 | Shares | Sole | 2023-03-08 | |
| 2022-09-30 | $2,302,913 | 52,626 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $2,801,177 | 53,427 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $2,874,322 | 55,521 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $3,528,828 | 59,760 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $2,349,120 | 54,618 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $1,913,670 | 48,868 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $1,741,757 | 48,075 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $1,748,106 | 47,490 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $1,754,845 | 47,816 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $1,469,016 | 44,924 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $1,387,459 | 42,508 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||